Why the study?
The study investigated using fully automated abdominal CT-based biometric measures for opportunistic identification of metabolic syndrome in adults without symptoms.
Can fully automated abdominal CT-based biomarkers opportunistically identify metabolic syndrome in asymptomatic adults?
Can fully automated abdominal CT-based biomarkers opportunistically identify metabolic syndrome in asymptomatic adults?
Fully automated quantitative tissue measures from routine abdominal CT scans can opportunistically and accurately identify individuals at risk for metabolic syndrome.
May support opportunistic metabolic syndrome screening on routine CT; leaves open prospective validation before practice change.
OBJECTIVE: Metabolic syndrome describes a constellation of reversible cardiometabolic abnormalities associated with cardiovascular risk and diabetes. The present study investigates the use of fully automated abdominal CT-based biometric measures for opportunistic identification of metabolic syndrome in adults without symptoms. MATERIALS AND METHODS: International Diabetes Federation criteria were applied to a cohort of 9223 adults without symptoms who underwent unenhanced abdominal CT. After patients with insufficient clinical data for diagnosis were excluded, the final cohort consisted of 7785 adults (mean age, 57.0 years; 4361 women and 3424 men). Previously validated and fully automated CT-based algorithms for quantifying muscle, visceral and subcutaneous fat, liver fat, and abdominal aortic calcification were applied to this final cohort. RESULTS: was 80.1% sensitive and 85.4% specific for metabolic syndrome. For women, the AUROC was 0.930 when fat and muscle measures were combined. CONCLUSION: Fully automated quantitative tissue measures of fat, muscle, and liver derived from abdominal CT scans can help identify individuals who are at risk for metabolic syndrome. These visceral measures can be opportunistically applied to CT scans obtained for other clinical indications, and they may ultimately provide a more direct and useful definition of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Pickhardt et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: